ARCHIVES

ColoPrint Improves Prognosis In Stage II and III Colon Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Calabresi Named To President’s Cancer Panel; Mays Leaves NCI Technology Office For IVAX

May 5, 1995

NSAIDs Cut Oral Cancer Risk But Raise Smokers’ Heart Risk

October 28, 2005

In Brief: Weldon Gage named CFO at MD Anderson Cancer Center

December 12, 2014

Frank Rauscher, 62, Former NCI director, Dead Of Heart Attack

January 8, 1993

NCI Pulls Back Curtain on “Zone of Uncertainty” — Funding Patterns Released With Little Comment

May 4, 2012

Compendium Drops Listing of Aranesp for Anemia of Cancer.

February 23, 2007